ArticleJournal of thoracic disease2026
Ten-year survival, clinical durability, and physiological resilience of minimally invasive versus sternotomy coronary artery bypass grafting: propensity-matched analysis.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Although early safety of minimally invasive coronary artery bypass grafting (MICS-CABG) is validated, concerns regarding long-term clinical durability and survival relative to conventional sternotomy persist. The study aims to evaluate 10-year survival and major adverse cardiac and cerebrovascular events (MACCE) of MICS-CABG. Methods: An ambispective cohort was assembled by retrospectively identifying consecutive patients who underwent isolated CABG between November 2015 and March 2019, with prospective follow-up initiated in 2020 under a standardized protocol. Propensity-score matching (1:1) yielded 244 pairs (n=488 total). The primary endpoint was 10-year survival. Secondary endpoints included MACCE (death, myocardial infarction, stroke, or repeat revascularization). Results: In the matched cohort (median follow-up, 93 months), MICS-CABG was associated with superior 10-year survival compared with sternotomy-CABG (85.9% Conclusions: MICS-CABG was associated with higher 10-year survival rate and reduced MACCE risk compared with sternotomy-CABG, without compromising long-term clinical durability. The survival benefit was predominantly driven by reduced non-cardiac mortality which suggest that sternal-sparing approach may preserve physiological reserve, thereby enhancing patient resilience against systemic stressors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.